Motivational Interviewing to Prevent Suicide in High Risk Veterans
Status: | Completed |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/17/2018 |
Start Date: | July 30, 2012 |
End Date: | December 5, 2017 |
The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to
Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically
hospitalized Veterans at high risk for suicide.
Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically
hospitalized Veterans at high risk for suicide.
Veterans who receive health care from the VA are at elevated risk for suicide, and the number
of Veterans at high risk may be growing. Although the months following discharge from
psychiatric hospitalization are a period of acute risk for Veterans, there is a dearth of
empirically supported treatments tailored to psychiatric inpatients and no studies examining
treatments for psychiatrically hospitalized Veterans. This randomized controlled trial will
test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation
(MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high
risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at
the Syracuse VA Medical Center. To meet high-risk criteria, Veterans must score over two on
the Beck Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by
suicide. Participants will complete a screening assessment to confirm eligibility and a
baseline assessment of risk factors for suicide. They will be randomized to receive
Motivational Interviewing to Address Suicidal Ideation (MI-SI) plus treatment as usual (TAU),
or TAU alone. The MI-SI group will receive two sessions of MI-SI during hospitalization and
one telephone booster session after discharge. Participants in both conditions will be asked
to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in
the severity of suicidal ideation will be measured using the SSI.
of Veterans at high risk may be growing. Although the months following discharge from
psychiatric hospitalization are a period of acute risk for Veterans, there is a dearth of
empirically supported treatments tailored to psychiatric inpatients and no studies examining
treatments for psychiatrically hospitalized Veterans. This randomized controlled trial will
test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation
(MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high
risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at
the Syracuse VA Medical Center. To meet high-risk criteria, Veterans must score over two on
the Beck Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by
suicide. Participants will complete a screening assessment to confirm eligibility and a
baseline assessment of risk factors for suicide. They will be randomized to receive
Motivational Interviewing to Address Suicidal Ideation (MI-SI) plus treatment as usual (TAU),
or TAU alone. The MI-SI group will receive two sessions of MI-SI during hospitalization and
one telephone booster session after discharge. Participants in both conditions will be asked
to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in
the severity of suicidal ideation will be measured using the SSI.
Inclusion Criteria:
- Veteran status,
- admitted to psychiatric inpatient unit,
- age 18 and over,
- English speaking,
- able to understand the study and provide informed consent,
- clinically cleared to participate by unit staff,
- receive health care from a VA facility in upstate NY,
- at increased risk for suicide (Beck Scale for Suicidal Ideation [SSI] > 2)
Exclusion Criteria:
- current psychosis,
- current mania,
- dementia,
- prisoner status,
- being inaccessible and discharged from the unit less than 48 hours after being
identified by study staff
We found this trial at
1
site
Syracuse, New York 13210
Principal Investigator: Peter C Britton, PhD MS
Phone: 315-425-4400
Click here to add this to my saved trials